6L96
Structure of PPARalpha-LBD/pemafibrate/SRC1 peptide
Summary for 6L96
Entry DOI | 10.2210/pdb6l96/pdb |
Descriptor | Peroxisome proliferator-activated receptor alpha, SRC1 coactivator peptide, (2~{R})-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid (3 entities in total) |
Functional Keywords | transcription |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 3 |
Total formula weight | 64835.42 |
Authors | Kawasaki, M.,Kambe, A.,Yamamoto, Y.,Arulmozhira, S.,Ito, S.,Nakagawa, Y.,Tokiwa, H.,Nakano, S.,Shimano, H. (deposition date: 2019-11-08, release date: 2020-01-15, Last modification date: 2023-11-22) |
Primary citation | Kawasaki, M.,Kambe, A.,Yamamoto, Y.,Arulmozhiraja, S.,Ito, S.,Nakagawa, Y.,Tokiwa, H.,Nakano, S.,Shimano, H. Elucidation of Molecular Mechanism of a Selective PPAR alpha Modulator, Pemafibrate, through Combinational Approaches of X-ray Crystallography, Thermodynamic Analysis, and First-Principle Calculations. Int J Mol Sci, 21:-, 2020 Cited by PubMed: 31935812DOI: 10.3390/ijms21010361 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.2 Å) |
Structure validation
Download full validation report